Simmunome AI
ActiveAI-nativeIncreasing Clinical Trial Efficacy, One Disease at a Time
What it does
"Simmunome AI is a pioneering health company focused on increasing clinical trial efficacy through artificial intelligence. Utilizing machine-learning driven, biologically accurate disease models, Simmunome offers a unique approach to predicting clinical trial outcomes before entering the lab. By replicating biological complexity with AI, their solution enables researchers to de-risk clinical programs and optimize drug development pipelines. With the potential to save organizations millions of dollars and prevent years of opportunity cost, Simmunome's innovative approach has the power to revolutionize the healthcare industry. By providing a predictive disease model that assesses the efficacy of targeting different biological systems, Simmunome is at the forefront of leveraging AI and machine learning to drive advancements in clinical research."
Its site says now · captured 2026-08-23
Simmunome Inc.
Simmunome offers a genAI platform that utilizes mechanistic modeling combined with machine learning to simulate the efficacy and safety of drug targets, enhancing transnational R&D.
Next to it in Healthcare and bio · AI clinical trial optimization
- BiorcePlug and Play
Revolutionizing drug development through the power of AI.
- Elligo Health ResearchPlug and Play
Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems.
- Infiuss HealthPlug and Play
Bringing global clinical Research and clinical trials direct-to-African participants
- Perceiv AIPlug and Play
AI-driven precision medicine for clinical trials
- Massive Bio500 Global
Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.
- CurebaseY Combinator S18
Modern, AI-powered clinical trial software platform.
- ComprehendY Combinator W11
SaaS to increase speed and quality of clinical trials.
- AkidoPlug and Play
Akido Labs blends AI technology and clinical ops, empowering non-physician staff, allowing physicians to supervise more patients while maintaining quality. Their AI-first approach, via ScopeAI and the Akido Care network, is gaining traction.